{"title":"The teratogenicity of antirheumatic drugs--what is the evidence?","authors":"B Källén","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>This review addresses on various methods used in the detection of human teratogenic effects of drug use in early pregnancy. Data are presented from the new Swedish ongoing recording of drug use in early pregnancy. These data do not indicate a teratogenic effect of the main antirheumatic drugs used in Sweden.</p>","PeriodicalId":21501,"journal":{"name":"Scandinavian journal of rheumatology. Supplement","volume":"107 ","pages":"119-24"},"PeriodicalIF":0.0000,"publicationDate":"1998-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scandinavian journal of rheumatology. Supplement","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
This review addresses on various methods used in the detection of human teratogenic effects of drug use in early pregnancy. Data are presented from the new Swedish ongoing recording of drug use in early pregnancy. These data do not indicate a teratogenic effect of the main antirheumatic drugs used in Sweden.